Sign Up Today and Learn More About Visby Medical Stock
Invest in or calculate the value of your shares in Visby Medical or other pre-IPO companies through EquityZen's platform.
About Visby Medical Stock
Founded
2012
Headquarters
San Jose, CA, US
Industries
Administrative Services, Sports, Content and Publishing
Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools that are both highly accurate and delightful to use.
Visby Medical Press Mentions
Stay in the know about the latest news on Visby Medical
Molecular diagnostic devices and methods
patents • Apr 02, 2025
Visby Medical Wins De Novo Nod for OTC PCR Test for Women’s Sexual Health
mpo-mag • Mar 31, 2025
PCR Comes to the Home With FDA Authorization of Visby’s OTC Sexual Health Test
medcitynews • Mar 30, 2025
Visby Medical nets FDA clearance for completely at-home STI test
fiercebiotech • Mar 29, 2025
FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis
prnewswire • Mar 28, 2025
Investors in Visby Medical
Discover investors in Visby Medical stock and explore their portfolio companies
Visby Medical Management
Leadership team at Visby Medical
Chief Executive Officer
Adam de la Zerda
Chief Financial Officer
Mark Ibison
Join now and verify your accreditation status to gain access to:
- Visby Medical Current Valuation
- Visby Medical Stock Price
- Visby Medical Management
- Available deals in Visby Medical and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Visby Medical Cap Table and Funding History by Share Class and Liquidity Preferences
- Visby Medical Revenue and Financials
- Visby Medical Highlights
- Visby Medical Business Model
- Visby Medical Risk Factors
- Visby Medical Research Report from SACRA Research
Trading Visby Medical Stock
How to invest in Visby Medical stock?
Accredited investors can buy pre-IPO stock in companies like Visby Medical through EquityZen funds. These investments are made available by existing Visby Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Visby Medical stock?
Shareholders can sell their Visby Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
